Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NPD-1902
- Development stage
- Preclinical
- Lead developer
- Nogra Pharma Ltd.
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
NPD-1902 is an oligonucleotide therapeutic under development by Nogra Pharma for the treatment of immune-inflammatory-mediated diseases, with a specific focus on Crohn's disease. Part of the company's proprietary oligonucleotide platform, NPD-1902 is designed to modulate disease-associated protein expression by down-regulating target proteins involved in inflammatory pathways. While the specific molecular target remains undisclosed, the candidate is currently in the formulation development stage of preclinical research, following the company's strategy of utilizing oligonucleotide-based modalities to address chronic inflammatory conditions.
Beyond the preview
Go deeper on NPD-1902.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NPD-1902.